Open study for the evaluation of the effectiveness of insulin buccal spray on metabolic control in patients with impaired glucose tolerance (PREVORAL study 2) [Studio aperto per la valutazione dell efficacia dell insulina spray buccale sul controllo glicometabolico in soggetti con ridotta tolleranza ai carboidrati (studio PREVORAL 2)]

Trial Profile

Open study for the evaluation of the effectiveness of insulin buccal spray on metabolic control in patients with impaired glucose tolerance (PREVORAL study 2) [Studio aperto per la valutazione dell efficacia dell insulina spray buccale sul controllo glicometabolico in soggetti con ridotta tolleranza ai carboidrati (studio PREVORAL 2)]

Completed
Phase of Trial: Phase II

Latest Information Update: 05 Oct 2012

At a glance

  • Drugs Insulin (Primary)
  • Indications Glucose intolerance; Hyperglycaemia; Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Acronyms PREVORAL2
  • Most Recent Events

    • 05 Oct 2012 Results presented at the 48th Annual Meeting of the European Association for the Study of Diabetes.
    • 05 Oct 2012 Status changed from active, no longer recruiting to completed, based on the abstract presented at EASD.
    • 08 Dec 2011 Results presented at the 21st World Diabetes Congress.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top